This inventor holds 3 USPTO granted patents. Top assignees: University of Pennsylvania, Other. Active years: 1998-2002.
Location History:
- Philadelphia, PA (US) (1998)
- Oak Park, IL (US) (2000 - 2002)
Company Filing History:
2 out of 2,651 
1 out of 834,411 Years Active: 1998-2002
Title: Fraser Aird: Innovator in Corticotropin Release Inhibiting Factor Research
Introduction
Fraser Aird is a notable inventor based in Oak Park, IL (US). He has made significant contributions to the field of biochemistry, particularly in the development of corticotropin release inhibiting factors. With a total of 3 patents, Aird's work has implications for understanding and treating various diseases related to hormone regulation.
Latest Patents
Fraser Aird's latest patents include innovative methods and compositions related to corticotropin release inhibiting factors. One of his patents, titled "Corticotropin release inhibiting factor and methods of using same," describes a substantially pure preparation of a CRIF peptide. This peptide consists of three to twenty-one or twenty-five contiguous amino acids found within the amino acid sequence of the prepro-TRH protein. Another significant patent, "Corticotropin release inhibiting factor and methods of using same for," details a peptide with CRIF activity, which includes at least three contiguous amino acids from the same sequence. This invention also encompasses methods for diagnosing and treating diseases related to CRIF.
Career Highlights
Fraser Aird has had a distinguished career, working at the University of Pennsylvania, where he has contributed to various research projects. His work has been pivotal in advancing the understanding of hormone regulation and its effects on health.
Collaborations
Throughout his career, Aird has collaborated with esteemed colleagues, including Eva E Redei and Peter A Rittenhouse. These collaborations have enriched his research and expanded the impact of his inventions.
Conclusion
Fraser Aird's innovative work in the field of corticotropin release inhibiting factors showcases his dedication to advancing medical science. His patents reflect a commitment to developing new methods for diagnosing and treating hormone-related diseases.